Barnette
Veru Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Barnette as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07446998 · Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossVeru Inc. · active not recruiting · Obesity & Overweight, Mobility Disability, HOMA-IR · study chair
- Ph2NCT06282458 · Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtVeru Inc. · completed · Muscle Loss, Obesity · study chair
- Ph2NCT05079360 · Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerVeru Inc. · withdrawn · Metastatic Breast Cancer · study chair
- Ph3NCT05065411 · Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerVeru Inc. · terminated · Metastatic Breast Cancer · study chair
- Ph2NCT05008510 · P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .Veru Inc. · withdrawn · Metastatic Triple Negative Breast Cancer · study chair
- Ph3NCT04869943 · Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerVeru Inc. · terminated · Metastatic Breast Cancer · study chair
- Ph3NCT04844749 · Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentVeru Inc. · terminated · Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer · study chair
- Ph3NCT04842747 · VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyVeru Inc. · completed · SARS-CoV Infection · study chair
- Ph2NCT04388826 · COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111Veru Inc. · completed · Respiratory Distress Syndrome, Adult · study director
- Ph1/Ph2NCT03752099 · To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerVeru Inc. · terminated · Metastatic Castration Resistant Prostate Cancer · study chair
- Ph2NCT03646162 · Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerVeru Inc. · completed · Prostate Cancer Metastatic · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.